LATS1 and metabolic dysfunction-associated steatohepatitis: At the same time, LATS1, LATS2, AMOTL2, SOX11, NF2, LncRNAs-RPARP-AS1, and SRD5A3-AS1 were significantly suppressed in both NASH groups, in comparison to the Normal group.